178 related articles for article (PubMed ID: 32866820)
1. Desensitization of metastatic melanoma cells to therapeutic treatment through repeated exposure to dacarbazine.
Biteghe FAN; Padayachee E; Davids LM; Chalomie NET; Ndong JC; Barth S
J Photochem Photobiol B; 2020 Oct; 211():111982. PubMed ID: 32866820
[TBL] [Abstract][Full Text] [Related]
2. A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells.
Biteghe FN; Davids LM
J Photochem Photobiol B; 2017 Jan; 166():18-27. PubMed ID: 27852006
[TBL] [Abstract][Full Text] [Related]
3. Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells.
Baglo Y; Liang BJ; Robey RW; Ambudkar SV; Gottesman MM; Huang HC
Cancer Lett; 2019 Aug; 457():110-118. PubMed ID: 31071369
[TBL] [Abstract][Full Text] [Related]
4. The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.
Wouters J; Stas M; Gremeaux L; Govaere O; Van den Broeck A; Maes H; Agostinis P; Roskams T; van den Oord JJ; Vankelecom H
PLoS One; 2013; 8(10):e76550. PubMed ID: 24098529
[TBL] [Abstract][Full Text] [Related]
5. St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death.
Kleemann B; Loos B; Scriba TJ; Lang D; Davids LM
PLoS One; 2014; 9(7):e103762. PubMed ID: 25076130
[TBL] [Abstract][Full Text] [Related]
6. Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery.
Damke GMZF; Souza RP; Montanha MC; Damke E; Gonçalves RS; César GB; Kimura E; Caetano W; Hioka N; Consolaro MEL
Anticancer Agents Med Chem; 2020; 20(11):1352-1367. PubMed ID: 30387402
[TBL] [Abstract][Full Text] [Related]
7. Hypericin photodynamic activity in DPPC liposomes - part II: stability and application in melanoma B16-F10 cancer cells.
de Morais FAP; Gonçalves RS; Vilsinski BH; Lazarin-Bidóia D; Balbinot RB; Tsubone TM; Brunaldi K; Nakamura CV; Hioka N; Caetano W
Photochem Photobiol Sci; 2020 May; 19(5):620-630. PubMed ID: 32248218
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer.
Khot MI; Perry SL; Maisey T; Armstrong G; Andrew H; Hughes TA; Kapur N; Jayne DG
Photodiagnosis Photodyn Ther; 2018 Sep; 23():221-229. PubMed ID: 29969677
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy.
Jendželovský R; Jendželovská Z; Kuchárová B; Fedoročko P
Biomed Pharmacother; 2019 Jan; 109():2173-2181. PubMed ID: 30551474
[TBL] [Abstract][Full Text] [Related]
10. Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells.
Gupta P; Zhang YK; Zhang XY; Wang YJ; Lu KW; Hall T; Peng R; Yang DH; Xie N; Chen ZS
Cell Physiol Biochem; 2018; 45(4):1515-1528. PubMed ID: 29486476
[TBL] [Abstract][Full Text] [Related]
11. Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis.
Hu J; Song J; Tang Z; Wei S; Chen L; Zhou R
Eur J Pharmacol; 2021 Jun; 900():174071. PubMed ID: 33811836
[TBL] [Abstract][Full Text] [Related]
12. Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.
Jendzelovský R; Mikes J; Koval' J; Soucek K; Procházková J; Kello M; Sacková V; Hofmanová J; Kozubík A; Fedorocko P
Photochem Photobiol Sci; 2009 Dec; 8(12):1716-23. PubMed ID: 20024169
[TBL] [Abstract][Full Text] [Related]
13. Differential susceptibility of primary cultured human skin cells to hypericin PDT in an in vitro model.
Popovic A; Wiggins T; Davids LM
J Photochem Photobiol B; 2015 Aug; 149():249-56. PubMed ID: 26114219
[TBL] [Abstract][Full Text] [Related]
14. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
[TBL] [Abstract][Full Text] [Related]
15. Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.
Morgan J; Jackson JD; Zheng X; Pandey SK; Pandey RK
Mol Pharm; 2010 Oct; 7(5):1789-804. PubMed ID: 20684544
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy-induced killing is enhanced in depigmented metastatic melanoma cells.
Sharma KV; Bowers N; Davids LM
Cell Biol Int; 2011 Sep; 35(9):939-44. PubMed ID: 21542806
[TBL] [Abstract][Full Text] [Related]
17. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
18. Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine.
Singh S; Davis R; Alamanda V; Pireddu R; Pernazza D; Sebti S; Lawrence N; Chellappan S
Mol Cancer Ther; 2010 Dec; 9(12):3330-41. PubMed ID: 21139044
[TBL] [Abstract][Full Text] [Related]
19. Hypericin affects cancer side populations via competitive inhibition of BCRP.
Vargová J; Mikeš J; Jendželovský R; Mikešová L; Kuchárová B; Čulka Ľ; Fedr R; Remšík J; Souček K; Kozubík A; Fedoročko P
Biomed Pharmacother; 2018 Mar; 99():511-522. PubMed ID: 29665654
[TBL] [Abstract][Full Text] [Related]
20. Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.
Hardy KM; Strizzi L; Margaryan NV; Gupta K; Murphy GF; Scolyer RA; Hendrix MJ
Mol Cancer Res; 2015 Apr; 13(4):670-80. PubMed ID: 25767211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
